Skip to main content

Google offers more hope Night Mode might return for Nexus phones on Nougat

Image result for nougat android
Many owners of Google’s older Nexus phones were not happy when Android 7.0 Nougat was released, as it removed the popular Night Mode feature from those phones. There have been a number of third-party mods to bring it back, but now it appears that Google maybe (just maybe) is preparing for its official return.
For those of you who are coming into this debate late, Night Mode is supposed to offer smartphone owners a way to use them more easily in the dark by applying a blue-light filter toggle. Google made the decision to ditch Night Mode from the first Android 7.0 release, due to what the company said were performance issues with the feature. It is available on Android 7.1.1. for the new Pixel and Pixel XL phones, under the term Night Light.
Many fans have since posted “bug reports” on Google’s developer forums, requesting the return of Night Mode on Nexus phones with Nougat. Now, one such forum request has been closed by Google, and its status has been changed to “FutureRelease”. Obviously, this doesn’t mean the company is definitely going to bring this feature back, but it is an encouraging little sign. Hopefully we will get more information on this development in the very near future.

Comments

Popular posts from this blog

The Secret Science 02:The 30 Most Disturbing Human Experiments in History

Disturbing human experiments aren’t something the average person thinks too much about. Rather, the progress achieved in the last 150 years of human history is an accomplishment we’re reminded of almost daily. Achievements made in fields like biomedicine and psychology mean that we no longer need to worry about things like deadly diseases or masturbation as a form of insanity. For better or worse, we have developed more effective ways to gather information, treat skin abnormalities, and even kill each other. But what we are not constantly reminded of are the human lives that have been damaged or lost in the name of this progress. The following is a list of the 30 most disturbing human experiments in history. 30. The Tearoom Sex Study Sociologist Laud Humphreys often wondered about the men who commit impersonal sexual acts with one another in public restrooms. He wondered why “tearoom sex” — fellatio in public restrooms — led to the majority of homosexual arrests in ...

The Strange and Stranger Case of Wyndham Lathem

A Northwestern University plague researcher has been charged with a brutal murder. Here’s what we know about him. WIKIMEDIA,  TONY WEBSTER O n July 27,  The  Chicago Tribune   reported that there was an arrest warrant issued for  Wyndham Lathem , a microbiologist at Northwestern University. The crime Lathem would later be charged with was brutal—26-year-old Trenton James Cornell-Duranleau, whose body was found in Lathem’s apartment, had been stabbed dozens of times. But Lathem was nowhere to be found. As events unfolded over the following days, it became clear he had fled from Chicago to California with a second suspect, 56-year-old Andrew Warren, a University of Oxford employee from the United Kingdom visiting the states. Along the way, the two men apparently made an anonymous $1,000 donation in Cornell-Duranleau’s name to the Lake Geneva Public Library and another donation for $5,610 to a Chicago health center. Lathem had also sent a video to fa...

Popular painkiller doesn’t have more heart risks than others, study claims

NEW ORLEANS — A long-awaited study on painkillers called nonsteroidal anti-inflammatory drugs, the most widely prescribed class of drugs in the world, has concluded that the three most commonly used carry a similar risk of cardiovascular complications. Yet critics say the study was too flawed to fairly compare them. Concerns about a type of NSAID called COX-2 inhibitors peaked in 2004 when the drug Vioxx was withdrawn from the market — a decision steeped in scandal because manufacturer Merck & Co had initially hidden data that would reveal the drug’s cardiovascular risks. A second COX-2 inhibitor, Pfizer Inc.’s Celebrex, was allowed to remain on the market with the condition that Pfizer conduct a study to prove that Celebrex was no worse than two older NSAIDs, naproxen and ibuprofen. The study lasted 10 years and enrolled more than 24,000 patients, but faced challenges. Doctors in European Union countries would not participate because they were worried a...